In 2010, Al Omar et al17 reported that there were no significant differences in the proportion of patients with different KIR genes, genotypes and haplotypes among patients with solid tumors (NSCLC, small-cell lung cancer, colon cancer and kidney cancer). This evidence concerns the gene KIR3DL1 and kidney cancer.